RICE HALL JAMES & ASSOCIATES, LLC
Position in OBIO — Orchestra BioMed Holdings, Inc.
CIK 1230765
San Diego, CA
Position in OBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$80,754
New position
Shares Held
19,001
first reported quarter
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 95.0371033103521.ToString("F0")%
Shared 0.ToString("F0")%
None 4.962896689647913.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $211,400,940 across 22 Biotechnology names. OBIO ranks #22 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
283,567 | $56,614,151 | |
| 2 | ASND |
Ascendis Pharma A/S
|
148,386 | $33,940,329 | |
| 3 | VRDN |
Viridian Therapeutics, Inc.\DE
|
898,611 | $17,576,831 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
617,489 | $13,745,305 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
147,037 | $13,583,278 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
770,711 | $11,144,481 | |
| 7 | TSHA |
Taysha Gene Therapies, Inc.
|
1,944,671 | $8,692,679 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
487,898 | $7,230,648 |
All Filings in OBIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $80,754 | 19,001 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||